Dublin, Sept. 07, 2022 (GLOBE NEWSWIRE) -- The "Laxatives Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030" report has been added to ResearchAndMarkets.com's offering.
The global laxatives market is rising at a significant pace, projected to rise at a CAGR of 5.5% during the estimated period from 2022 to 2030, starting from US$ 6,063.8 Mn in 2021.
Constipation is one of the most common conditions diagnosed in clinical practice, with up to one-fifth of the general population suffering from chronic constipation. Certain studies have reported 24% to 50% prevalence in older adults. It is also observed that between 10% and 18% of geriatrics in community dwellings and 74% of residents in nursing homes regularly use laxatives.
Constipation can have a significant impact on the everyday functions and the quality of life of patients. Severe cases of constipation may also lead to coronary episodes, cerebral ischemia, and syncope. In order to mitigate the complications arising from uncontrolled or un-managed constipation, several types of laxatives are frequently prescribed to such patients, particularly to those belonging to the higher age group.
Constipation can be treated with home remedies such as adding fiber to the diet, regular exercise, and increasing the intake of fluids. Home remedies are effective in the treatment of mild cases of constipation. However, laxatives are the drugs that are utilized to treat severe as well as mild cases of constipation. These laxatives have different mechanisms to cure constipation and have distinct variations from one drug to another.
Drug classes including psyllium and methylcellulose act by increasing the bulk in the stool, creating an outcome that causes the movement of the intestines. Hence, these drug classes are also known as bulk-forming laxatives. Furthermore, a few drugs work by cumulating the volume of water in the stool, creating the stool laxer and easier to pass. Drug compounds such as senna and bisacodyl are known as stimulant laxatives. Stimulant laxatives work by inducing a bowel movement by acting to speed up colonic muscle movement.
In addition, lockdown restrictions and the need to maintain social distancing due to the ongoing COVID-19 pandemic have resulted in more people staying at home. Hence, a sedentary lifestyle has resulted in the development of chronic constipation. In addition, increasing demand for junk food drastically alters the bowel peristaltic activity causing hardening of stool, thereby the laxatives market is expected to witness significant growth during the forecast period from 2022 to 2030.
Increasing demand for junk food will boost the laxative market in North America
In 2021, North America dominated the regional laxatives market, due to the strong existence of all the major Rx and OTC laxative drugs, higher consciousness about constipation and its rapid treatment are the main factors contributing to the prominent position of not only laxatives but the overall digestive remedies drugs market in North America. The presence of major market players such as Bayer AG, Boehringer Ingelheim Pharmaceuticals, Inc., GlaxoSmithKline, Plc. and others fur further support the positive market growth in the region.
Increasing geriatric pool will spur the market in the Asia Pacific region
The Asia Pacific region is expected to be the fastest-growing region during the forecast period owing to the increasing geriatric pool with altered bowel peristaltic activity. Furthermore, the constant rise in sedentary lifestyle and growing inclination for the consumption of fast food will further fortify the market growth in the Asia Pacific region. This report is a comprehensive research study of the global laxatives market that elaborates the major trends in the market based on quantitative and qualitative research. This report provides a detailed description of the global laxatives market segmenting market by drug types and geography. This report aids the market stakeholders to make improved decisions and strategies in the laxatives market.
Historical - Forecast Period
This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Key questions answered in this report
What are the key micro and macro environmental factors that are impacting the growth of Laxatives market?
What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
Estimated forecast and market projections up to 2030.
Which segment accounts for the fastest CAGR during the forecast period?
Which market segment holds a larger market share and why?
Are low and middle-income economies investing in the Laxatives market?
Which is the largest regional market for Laxatives market?
What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East - Africa?
Which are the key trends driving Laxatives market growth?
Who are the key competitors and what are their key strategies to enhance their market presence in the Laxatives market worldwide?
Key Topics Covered:
2. Executive Summary
3. Laxatives Market: Business Outlook & Market Dynamics
3.2. Global Laxatives Market Value, 2020 - 2030, (US$ Million)
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.2. Market Restraints
3.3.3. Key Challenges
3.3.4. Key Opportunities
3.4. Impact Analysis of Drivers and Restraints
3.5. See-Saw Analysis
3.6. Porter's Five Force Model
3.6.1. Supplier Power
3.6.2. Buyer Power
3.6.3. Threat Of Substitutes
3.6.4. Threat Of New Entrants
3.6.5. Competitive Rivalry
3.7. PESTEL Analysis
3.7.1. Political Landscape
3.7.2. Economic Landscape
3.7.3. Technology Landscape
3.7.4. Legal Landscape
3.7.5. Social Landscape
3.8. Heptalysis Analysis
3.9. Critical Investigation of Business Problems Through Five Whys Root Cause Analysis & Relevant Solutions
4. Laxatives Market: By Drug Type, 2020-2030, USD (Million)
4.1. Market Overview
4.2. Growth & Revenue Analysis: 2021 Versus 2030
4.3. Market Segmentation
4.3.1. Bulk-forming Agents
4.3.2. Emollients (Stool Softeners)
4.3.3. Lubricating Agents
4.3.4. Stimulating Agents
4.3.5. Hyperosmotic Agents
4.3.6. Saline Laxative Agents
4.3.7. Chloride Channel Activators
5. Laxatives Market: By Availability, 2020-2030, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2021 Versus 2030
5.3. Market Segmentation
5.3.1. Over-the-counter (OTC)
6. Laxatives Market: By Route of Administration, 2020-2030, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2021 Versus 2030
6.3. Market Segmentation
7. North America Laxatives Market, 2020-2030, USD (Million)
8. UK and European Union Laxatives Market, 2020-2030, USD (Million)
9. Asia Pacific Laxatives Market, 2020-2030, USD (Million)
10. Latin America Laxatives Market, 2020-2030, USD (Million)
11. Middle East and Africa Laxatives Market, 2020-2030, USD (Million)
12. Company Profile
12.1. Bayer AG
12.1.1. Company Overview
12.1.2. Financial Performance
12.1.3. Product Portfolio
12.1.4. Strategic Initiatives
12.2. Boehringer Ingelheim Pharmaceuticals, Inc.
12.2.1. Company Overview
12.2.2. Financial Performance
12.2.3. Product Portfolio
12.2.4. Strategic Initiatives
12.3. Braintree Laboratories, Inc.
12.3.1. Company Overview
12.3.2. Financial Performance
12.3.3. Product Portfolio
12.3.4. Strategic Initiatives
12.4. GlaxoSmithKline Consumer Healthcare, L.P.
12.4.1. Company Overview
12.4.2. Financial Performance
12.4.3. Product Portfolio
12.4.4. Strategic Initiatives
12.5. Procter & Gamble Company
12.5.1. Company Overview
12.5.2. Financial Performance
12.5.3. Product Portfolio
12.5.4. Strategic Initiatives
12.6. Purdue Pharma L.P.
12.6.1. Company Overview
12.6.2. Financial Performance
12.6.3. Product Portfolio
12.6.4. Strategic Initiatives
12.7. Sucampo Pharmaceuticals, Inc.
12.7.1. Company Overview
12.7.2. Financial Performance
12.7.3. Product Portfolio
12.7.4. Strategic Initiatives
For more information about this report visit https://www.researchandmarkets.com/r/kjh3do
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900